CONTI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 609
EU - Europa 503
AS - Asia 165
AF - Africa 1
Totale 1.278
Nazione #
US - Stati Uniti d'America 583
CN - Cina 94
SE - Svezia 86
UA - Ucraina 77
DE - Germania 60
IE - Irlanda 59
GB - Regno Unito 56
IT - Italia 46
FI - Finlandia 34
KR - Corea 34
FR - Francia 28
CA - Canada 26
DK - Danimarca 22
PL - Polonia 20
SG - Singapore 17
IN - India 10
VN - Vietnam 10
BE - Belgio 5
GR - Grecia 4
NL - Olanda 2
RU - Federazione Russa 2
CZ - Repubblica Ceca 1
MU - Mauritius 1
NO - Norvegia 1
Totale 1.278
Città #
Chandler 136
Beijing 67
Dublin 59
Ann Arbor 36
Milan 31
Jacksonville 27
Medford 26
Ashburn 23
Dearborn 23
Nyköping 20
Warsaw 20
Toronto 19
Woodbridge 18
Princeton 17
Fairfield 12
Houston 10
Pune 10
Düsseldorf 9
Verona 9
Villeurbanne 9
Wilmington 9
Singapore 8
Auburn Hills 7
Boardman 6
Lachine 6
Los Angeles 6
Brussels 5
Dong Ket 5
New York 5
Hefei 4
Nanjing 4
Chicago 3
Fremont 3
Kunming 3
Boston 2
Collegno 2
Grafing 2
Guangzhou 2
Mountain View 2
Nanchang 2
Norwalk 2
Phoenix 2
West Jordan 2
Zhengzhou 2
Baotou 1
Brno 1
Caraglio 1
Changzhi 1
Chengdu 1
Cincinnati 1
Colindale 1
Des Moines 1
Eindhoven 1
Falls Church 1
Fuzhou 1
Hebei 1
Jinan 1
Kharkiv 1
Pictou 1
Quzhou 1
Redmond 1
Redwood City 1
Seattle 1
Stavanger 1
Vaterstetten 1
Washington 1
Wuhan 1
Zhongxin 1
Totale 699
Nome #
Relation between EGF-R levels and tumour response to endocrine treatment in DMBA-induced mammary tumour. 125
Changes in the binding of oestradiol to uterine oestrogen receptors induced by some progesterone and 19-nor-testosterone derivatives. 114
[Correlation of the biochemical and histochemical determination of hormone receptors in carcinoma of the breast with the age of the patient, stage and histologic type of the neoplasm] 100
Correlation between pS2 protein positivity, steroid receptor status and other prognostic factors in breast cancer. 95
Correlations among receptor status, estrogen receptor (ER) form (8S and/or 4S) and labelling index (LI) in human breast cancer. 84
Effects of medroxyprogesterone acetate on DMBA-induced mammary tumors. 83
Effects of bromocriptine and dopamine on the binding of estradiol to its uterine cytoplasmic receptors. 80
Effects of estrogens P-1496 and P-1560 on the binding of estradiol with rat uterine estrogen receptors. 79
Histidine potentiates the antiproliferative effect of medroxyprogesterone acetate (MPA) on a human breast cancer cell line. 79
Histidine increases estrogen and progesterone receptor levels in rat mammary tumors. 70
Calcyclin, b-actin and H3-histone expression is modulated by sex steroids in hormone dependent human mammary cells (CG5) 66
[Distribution of estrogen receptors and progesterone receptors in the human uterus and influence of anesthetic drugs] 62
Ormonal modulation of human calcyclin gene expression 62
Estrogen and progesterone receptors in the human vagina. 62
[Prognostic value of receptor state determined by radiometric method in breast carcinoma] 61
Medroxyprogesterone acetate (MPA) stimulates adenylate cyclase activity in rat mammary tumours. 49
Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours 46
Totale 1.317
Categoria #
all - tutte 3.873
article - articoli 0
book - libri 0
conference - conferenze 690
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020195 12 28 30 9 16 36 20 5 14 9 13 3
2020/2021115 6 4 13 4 14 5 8 2 31 4 8 16
2021/2022185 0 3 8 7 1 2 22 8 6 32 55 41
2022/2023291 25 13 14 42 20 95 18 19 26 3 13 3
2023/2024111 13 30 3 3 5 32 0 1 0 6 2 16
Totale 1.317